...
首页> 外文期刊>Journal of immunotoxicology. >Allergic reactions compared between BN and Wistar rats after oral exposure to ovalbumin
【24h】

Allergic reactions compared between BN and Wistar rats after oral exposure to ovalbumin

机译:BN和Wistar大鼠口服卵清蛋白后的过敏反应比较

获取原文
           

摘要

There is currently no validated animal model for evaluating the potential allergenicity of food proteins. This study aimed to compare the allergic reactions between BN and Wistar rats after oral exposure to ovalbumin (OVA) by studying immune responses and clinical manifestations. Female BN and Wistar rats were orally exposed to OVA on days 1 and 14, and thereafter daily from day 15 to day 42. Sera and plasma were screened for OVA-specific antibodies and histamine. On day 49, all the OVA-sensitized animals were orally challenged with OVA before blood pressure was measured. One day later (on day 50), histopathology and differential cell counts were performed. The results indicate that oral exposure of BN rats to OVA yielded IgE, IgG, and IgG2a antibody responses that were generally of higher levels than those observed in Wistar rats (p < 0.05). However, the Wistar rats presented with more serious clinical manifestations and histopathologic changes that could have serious implications for any OVA-induced anaphylaxis. The studies here proved that OVA-sensitized BN and Wistar rats evinced different immune responses and clinical manifestations; these outcomes suggested that the two rat strains might differ in their immunologic mechanisms of allergy and that there was no correlation between immune responses and the severity of clinical symptoms. To be clear, the data from these studies should be viewed as ‘preliminary’, as only a single protein allergen was examined. Accordingly, further studies are needed to compare the allergic reactions between BN and Wistar rats by using purified strong-, weak-, and non-allergenic proteins based on the experiments reported here.
机译:目前尚无用于评估食物蛋白潜在致敏性的经过验证的动物模型。这项研究旨在通过研究免疫反应和临床表现,比较BN和Wistar大鼠口服卵清蛋白(OVA)后的过敏反应。将雌性BN和Wistar大鼠在第1天和第14天口服,然后从第15天到第42天每天接受OVA暴露。针对OVA特异性抗体和组胺筛选血清和血浆。在第49天,在测量血压之前,对所有OVA致敏的动物进行口服OVA攻击。一天后(第50天),进行了组织病理学和细胞计数。结果表明,BN大鼠口服OVA产生的IgE,IgG和IgG 2a 抗体反应的水平通常高于Wistar大鼠(p <0.05)。然而,Wistar大鼠表现出更严重的临床表现和组织病理学改变,可能对任何OVA引起的过敏反应有严重影响。此处的研究证明,OVA致敏的BN和Wistar大鼠表现出不同的免疫反应和临床表现。这些结果表明,这两种大鼠品系的变态反应的免疫学机制可能不同,并且免疫反应与临床症状的严重程度之间没有相关性。需要明确的是,这些研究的数据应被视为“初步”,因为仅检查了一种蛋白质过敏原。因此,基于本文报道的实验,需要使用纯化的强,弱和非过敏原蛋白比较BN和Wistar大鼠之间的过敏反应,这需要进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号